We are live on ! Find out more
ELI

ELITE PHARMACEUTICAL
ELI

Delisted

ELI was delisted on the 20th of May, 2009.

Back to rankings

2 hedge funds and large institutions have $37.2K invested in ELITE PHARMACEUTICAL in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

3% less capital invested

Capital invested by funds: $38.4K → $37.2K (-$1.23K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GA
1
Geneva Advisors
Illinois
$30K – – –
JAFL
2
Jay A. Fishman Ltd
Michigan
$7.2K – – –

ELI Hedge Fund Activity: Q4 2013 in Review

2 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ELITE PHARMACEUTICAL (ELI) for Q4 2013, worth a combined $37.2K — down 3.2% from $38.4K a quarter earlier.

Fund positioning in ELI was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held ELITE PHARMACEUTICAL (ELI) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $37.2K of ELITE PHARMACEUTICAL stock for Q4 2013, down 3.2% quarter-over-quarter.
  • 0 funds opened new ELITE PHARMACEUTICAL positions in Q4 2013 and 0 closed out.

Based on aggregated 13F filings for Q4 2013.